Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?

Background. Gastric varices (GV) are associated with high morbidity and mortality in patients with portal hypertension. Endoscopic cyanoacrylate injection is the first-line recommended therapy for GV obliteration. This study aims to explore the reason behind related adverse events and better prevent...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujen Tseng, Lili Ma, Tiancheng Luo, Xiaoqing Zeng, Yichao Wei, Ling Li, Pengju Xu, Shiyao Chen
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2018/1940592
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557043857227776
author Yujen Tseng
Lili Ma
Tiancheng Luo
Xiaoqing Zeng
Yichao Wei
Ling Li
Pengju Xu
Shiyao Chen
author_facet Yujen Tseng
Lili Ma
Tiancheng Luo
Xiaoqing Zeng
Yichao Wei
Ling Li
Pengju Xu
Shiyao Chen
author_sort Yujen Tseng
collection DOAJ
description Background. Gastric varices (GV) are associated with high morbidity and mortality in patients with portal hypertension. Endoscopic cyanoacrylate injection is the first-line recommended therapy for GV obliteration. This study aims to explore the reason behind related adverse events and better prevent its occurrence. Methods. A retrospective case series study was conducted from January 1, 2013, to December 31, 2016, to identify patients who experienced severe adverse events secondary to endoscopic cyanoacrylate injection. A literature review of similar cases was performed on two medical databases, Medline and Embase. Results. A total of 652 patients underwent cyanoacrylate injection at our center within the study duration. Five cases of severe adverse events related to the use of tissue adhesives were identified. Detailed clinical presentation, patient treatment, and outcomes were reviewed and analyzed. Twenty-seven similar cases were identified based on the literature review providing further insight into the study. Conclusion. Although rare in incidence, systemic embolism associated with cyanoacrylate injection is often fatal or debilitating. This report may raise awareness in treatment protocol, including the necessity of preoperative angiographic studies, to avoid similar adverse events in clinical practice.
format Article
id doaj-art-a0cfa6e6d6a8498a8f3772c066453519
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-a0cfa6e6d6a8498a8f3772c0664535192025-02-03T05:43:43ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972018-01-01201810.1155/2018/19405921940592Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?Yujen Tseng0Lili Ma1Tiancheng Luo2Xiaoqing Zeng3Yichao Wei4Ling Li5Pengju Xu6Shiyao Chen7Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Radiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Gastroenterology, Endoscopy Center and Evidence-Based Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, ChinaBackground. Gastric varices (GV) are associated with high morbidity and mortality in patients with portal hypertension. Endoscopic cyanoacrylate injection is the first-line recommended therapy for GV obliteration. This study aims to explore the reason behind related adverse events and better prevent its occurrence. Methods. A retrospective case series study was conducted from January 1, 2013, to December 31, 2016, to identify patients who experienced severe adverse events secondary to endoscopic cyanoacrylate injection. A literature review of similar cases was performed on two medical databases, Medline and Embase. Results. A total of 652 patients underwent cyanoacrylate injection at our center within the study duration. Five cases of severe adverse events related to the use of tissue adhesives were identified. Detailed clinical presentation, patient treatment, and outcomes were reviewed and analyzed. Twenty-seven similar cases were identified based on the literature review providing further insight into the study. Conclusion. Although rare in incidence, systemic embolism associated with cyanoacrylate injection is often fatal or debilitating. This report may raise awareness in treatment protocol, including the necessity of preoperative angiographic studies, to avoid similar adverse events in clinical practice.http://dx.doi.org/10.1155/2018/1940592
spellingShingle Yujen Tseng
Lili Ma
Tiancheng Luo
Xiaoqing Zeng
Yichao Wei
Ling Li
Pengju Xu
Shiyao Chen
Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
Canadian Journal of Gastroenterology and Hepatology
title Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
title_full Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
title_fullStr Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
title_full_unstemmed Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
title_short Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
title_sort thromboembolic events secondary to endoscopic cyanoacrylate injection can we foresee any red flags
url http://dx.doi.org/10.1155/2018/1940592
work_keys_str_mv AT yujentseng thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT lilima thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT tianchengluo thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT xiaoqingzeng thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT yichaowei thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT lingli thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT pengjuxu thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags
AT shiyaochen thromboemboliceventssecondarytoendoscopiccyanoacrylateinjectioncanweforeseeanyredflags